✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹260 Cr.
P/E
32.14
  • Sanjivani Paranteral
  • Kimia Biosciences
  • Sat Kartar Shopping
FAQs on Sanjivani Paranteral Ltd. Shareprice

Sanjivani Paranteral has given better returns compared to its competitors.
Sanjivani Paranteral has grown at ~29.39% over the last 9yrs while peers have grown at a median rate of 18.36%

Yes, Sanjivani Paranteral is expensive.
Latest PE of Sanjivani Paranteral is 33.13, while 3 year average PE is 22.29.
Also latest EV/EBITDA of Sanjivani Paranteral is 26.44 while 3yr average is 20.53.

Growth Table
  • Sanjivani Paranteral Ltd.
  • Kimia Biosciences
  • Sat Kartar Shopping
Balance Sheet
  • Sanjivani Paranteral Ltd.
  • Kimia Biosciences
  • Sat Kartar Shopping
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Sanjivani Paranteral Ltd.
  • Kimia Biosciences
  • Sat Kartar Shopping
Cash Flow
  • Sanjivani Paranteral Ltd.
  • Kimia Biosciences
  • Sat Kartar Shopping
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Sanjivani Paranteral Ltd.
  • Kimia Biosciences
  • Sat Kartar Shopping
Quarterly Results
  • Sanjivani Paranteral Ltd.
  • Kimia Biosciences
  • Sat Kartar Shopping
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Sanjivani Paranteral Ltd. Financials

Balance sheet of Sanjivani Paranteral is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Sanjivani Paranteral is increasing.
Latest net debt of Sanjivani Paranteral is ₹5.73 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹18.14 Crs.

Yes, profit is increasing.
The profit of Sanjivani Paranteral is ₹8.1 Crs for TTM, ₹6.17 Crs for Mar 2024 and ₹4.51 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sanjivani Paranteral latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech